Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Parkinson's
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia. The researchers compared the health outcomes of more than 110,
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
Some
Diabetes Meds
Could Lower Odds for Dementia, Parkinson's By Dennis Thompson HealthDay Reporter THURSDAY, Sept. 19, 2024 (HealthDay News) -- A specific class of
diabetes
drug appears to lower ...
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
Medical News Today
16h
Common diabetes drug may help slow organ aging, monkey study shows
The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...
1d
on MSN
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Healthshots on MSN
7d
What happens when you stop diabetes medication?
Diabetes is a chronic medical condition that affects the body’s ability to regulate blood sugar or glucose, a vital energy ...
ScienceAlert on MSN
3d
Common Diabetes Medication Slows Brain Aging in Monkeys
Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback